CTRI/2015/10/006250已完成未知
to study complications of intraviteral injection of bevacizumab
ETHRADHAMA SUPERSPECIALITY EYE HOSPITA0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Age > 18 years
- •Any evidence of ocular neovascularisation, Choroidal neovasular membrane, macular edema due to retinal vein occlusion, diabetic retinopathy
排除标准
- •Active external eye infection like conjunctivitis, meibomitis etc.
- •Ischemic maculopathy
- •Presence of any active systemic infections
研究者
相似试验
已完成
3 期
The study for the effect of intravitreous injection of ranibizumab (product name: Lucentis) and subthreshold laser photocoagulation on diabetic macular edemadiabetic macular edemaJPRN-UMIN000017037Jichi Medica University, Saitama Medical Center100
招募中
1 期
Investigating the effect of mesenchymal stem cell injection on reducing complications in patients with liver cirrhosisReducing complications of liver failure in patients with decompensated liver cirrhosis.Congenital cirrhosis (of liver)P78.81IRCT20140911019125N11Kerman University of Medical Sciences10
进行中（未招募）
不适用
Funktionelle Ergebnisse der intravitrealen Injektion von Triamcinolonacetonid im Vergleich zur konventionellen Lasertherapie bei diabetischem Makulaödem. - DME-TAEUCTR2004-005197-23-DEKlinik und Poliklinik für Augenheilkunde der Universität Regensburg40
进行中（未招募）
1 期
A Pilot Study Evaluating the Effect of Intravitreal Fluocinolone Acetonide (0.19mg) in Patients with Retinitis Pigmentosa.Retinitis Pigmetosa.MedDRA version: 19.0 Level: PT Classification code 10038914 Term: Retinitis pigmentosa System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-002523-28-GBMoorfields Eye Hospital1
已完成
不适用
Retrospective analysis of treatment with intravitreal injections in patients with AMD, DME and RVO in clinical practiceH35.3H34.8Degeneration of macula and posterior poleOther retinal vascular occlusionsDRKS00007999niversitäts-Augenklinik Freiburg1,269